Short videos about genetic testing for ovarian and endometrial cancer patients
Official title: Multimedia Aid for Genetic Testing in Gynecologic Oncology
Run by UNC Lineberger Comprehensive Cancer Center · NCT07084168 · Data updated 2026-11-12
This pilot will see if watching short English or Spanish videos helps patients with ovarian or endometrial cancer get genetic testing and referrals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | October 10, 2024 |
| Main results expected | October 30, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | November 12, 2025 |
| Trial ID | NCT07084168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a diagnosis of ovarian or endometrial cancer who are eligible for genetic testing, primarily English- or Spanish-speaking, who have not already completed genetic testing and who received their initial cancer-directed treatment at the study site.
✕Probably not a fit
Patients who have already completed genetic testing, who are not eligible for testing, or who cannot view the videos due to language or access barriers are unlikely to benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot implements short educational videos shown to adult patients with ovarian or endometrial cancer who are eligible for genetic testing. Participants will view one of three diagnosis-specific videos in English or Spanish and may complete a brief satisfaction survey. Investigators will perform a chart review comparing rates of genetic testing orders and genetics referrals before and after the videos are introduced. The project aims to estimate changes in testing and referral rates and collect patient feedback on the video materials.
Why it matters
Potential benefit: If successful, more eligible patients could receive genetic testing and counseling, enabling personalized treatment decisions and informing family members about inherited risk.
How similar studies have gone: Multimedia education has increased screening or testing uptake in other clinical areas, but evidence specifically for genetic testing in gynecologic oncology is limited and mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to participate in this study, a subject must meet all of the eligibility criteria outlined below. * Reviewed informed consent to participate in the study. * Subject is willing and able to comply with study procedures based on the judgment of the investigator. * Age ≥ 18 years at the time of consent. * Diagnosis of ovarian cancer or endometrial cancer * Eligible for genetic testing * English or Spanish is the primary language Exclusion Criteria: * Previously completed genetic testing * Did not receive initial cancer-directed treatment at study site
Where it's running
-
Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Katherine Tucker, MD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Luz Cuaboy
- Email: luz_cuaboy@med.unc.edu
- Phone: 919-843-5400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Fasting regimen for women undergoing chemotherapy after surgery for gynecologic cancers
This study is testing if an alternate day fasting diet can help women with ovarian and endometrial cancers feel better during chemotherapy and improve their quality of life.
-
Personalized navigation to support rural and Black women with endometrial cancer
This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
Liquid biopsy screening for early endometrial cancer in regional China
A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.